In this regard, the Bis-FAP/End-IL should accumulate in both tumor models based on binding to murine FAP expressing stromal cells such as myofibroblasts and pericytes and also to the murine endoglin expressing endothelial cells that make up the tumor vasculature. The gene discussed is FAP; the disease is neoplasm.